Karl Cahill
Oprichter bij MOSS GENOMICS INC.
Vermogen: 76 500 $ op 30-04-2024
Actieve functies van Karl Cahill
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MOSS GENOMICS INC. | Directeur/Bestuurslid | 11-01-2021 | - |
| Algemeen Directeur | 11-01-2021 | - | |
| Oprichter | 25-09-2018 | - |
Loopbaan van Karl Cahill
Eerdere bekende functies van Karl Cahill
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Concordia Resource Corp.
 Concordia Resource Corp. Other Metals/MineralsNon-Energy Minerals Concordia Resource Corp. is a junior exploration company with an emphasis on developing mineral deposits in Africa and South America. The company has an extensive exploration portfolio in the resource-endowed regions of Burkina Faso, Gabon, and the Democratic Republic of Congo. In addition, it holds interests in the La Providencia silver mine located in the Puna district of northwestern Argentina and also holds interests in the Cerro Amarillo-Cajon Grande copper-gold-molybdenum property located in the Malargüe District of Argentina. The company was founded on February 7, 2000 and is headquartered in Vancouver, Canada. | Investor Relations Contact | 05-04-2011 | 16-08-2012 |
| Public Communications Contact | 25-08-2011 | 16-08-2012 | |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Public Communications Contact | 15-04-2009 | 01-10-2009 |
| ABRASILVER RESOURCE CORP. | Investor Relations Contact | - | - |
Opleiding van Karl Cahill
| University of Westminster | Undergraduate Degree |
Statistieken
Internationaal
| Canada | 4 |
| Verenigde Staten | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Public Communications Contact | 2 |
| Investor Relations Contact | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Non-Energy Minerals | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ABRASILVER RESOURCE CORP. | Non-Energy Minerals |
| MOSS GENOMICS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Health Technology |
Concordia Resource Corp.
Concordia Resource Corp. Other Metals/MineralsNon-Energy Minerals Concordia Resource Corp. is a junior exploration company with an emphasis on developing mineral deposits in Africa and South America. The company has an extensive exploration portfolio in the resource-endowed regions of Burkina Faso, Gabon, and the Democratic Republic of Congo. In addition, it holds interests in the La Providencia silver mine located in the Puna district of northwestern Argentina and also holds interests in the Cerro Amarillo-Cajon Grande copper-gold-molybdenum property located in the Malargüe District of Argentina. The company was founded on February 7, 2000 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
- Beurs
- Insiders
- Karl Cahill
- Ervaring
